Catalyze Partners

Catalyze Partners, formerly Catalyze Dallas, is a Dallas-based venture development and technology commercialization firm that acquires or licenses market-ready technologies from large corporations and builds them into standalone portfolio companies. The company is not primarily a life sciences or healthcare operating company, but it has entered biotech through portfolio creation, including Almaden Genomics. Its model focuses on monetizing underutilized intellectual property, providing capital, operating leadership, commercialization strategy, and company-building support. Catalyze operates more like a holding company and venture builder than a drug developer, with activity spanning multiple industries including biotech, aerospace, advanced materials, and analytical instrumentation.